8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Feb 25, 2026·SEC
Material company update
Jan 14, 2026·SEC
LivaNova PLC(LIVN)Earnings, Financials & Key Ratios
LIVN•NASDAQ
Price updated Jun 19, 2026
AboutLivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.Show more
- Revenue$1.39B+10.7%
- EBITDA$241M+34.0%
- Net Income-$243M-483.5%
- EPS (Diluted)-4.45-483.6%
- Gross Margin67.71%-2.5%
- EBITDA Margin17.39%+21.0%
- Operating Margin14.37%+39.5%
- Net Margin-17.47%-446.3%
- ROE-19.24%-495.3%
LIVN Key Insights
LivaNova PLC (LIVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 83 (top 17%)
- ✓Trading near 52-week high
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when LIVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LIVN Price & Volume
LivaNova PLC (LIVN) stock price & volume — 10-year historical chart
Loading chart...
LIVN Growth Metrics
LivaNova PLC (LIVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years16.89%
5 Years8.24%
3 Years10.75%
TTM12.4%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM148.23%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM147.92%
Return on Capital
10 Years-2.25%
5 Years1.71%
3 Years4.33%
Last Year10.19%
LIVN Recent Earnings
LivaNova PLC (LIVN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.98+15.3%
$0.85
Rev
$362M+4.7%
$346M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.86+7.5%
$0.80
Rev
$361M+2.1%
$353M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$1.11+20.8%
$0.92
Rev
$358M+4.4%
$343M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$1.05+25.0%
$0.84
Rev
$353M+3.0%
$342M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.98vs $0.85+15.3% | $362Mvs $346M+4.7% |
| Q1 2026 | Feb 25, 2026 | $0.86vs $0.80+7.5% | $361Mvs $353M+2.1% |
| Q4 2025 | Nov 5, 2025 | $1.11vs $0.92+20.8% | $358Mvs $343M+4.4% |
| Q3 2025 | Aug 6, 2025 | $1.05vs $0.84+25.0% | $353Mvs $342M+3.0% |
Based on last 12 quarters of dataView full earnings history →
LIVN Peer Comparison
LivaNova PLC (LIVN) competitors in Neuromodulation and neuro devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 GKOS | 7.65B | 130.68 | -39.84 | 32.33% | -34.34% | -26.46% | 0.21 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 ELMD | 320.27M | 38.68 | 44.98 | 16.97% | 14.08% | 22.14% | 0.00 |
Compare LIVN vs Peers
LivaNova PLC (LIVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LIVN Income Statement
LivaNova PLC (LIVN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.01B | 1.11B | 1.08B | 934.24M | 1.04B | 1.02B | 1.15B | 1.25B | 1.39B | 1.43B |
Revenue Growth % | -16.61% | 9.35% | -2.06% | -13.83% | 10.82% | -1.31% | 12.89% | 8.66% | 10.74% | 12.4% |
Cost of Goods Sold | 360.7M | 372.5M | 360.37M | 339.48M | 329.37M | 314.58M | 382.3M | 382.56M | 448.2M | 466.12M |
COGS % of Revenue | 35.63% | 33.65% | 33.24% | 36.34% | 31.81% | 30.79% | 33.14% | 30.52% | 32.29% | - |
Gross Profit | 651.6M▲ 0% | 734.5M▲ 12.7% | 723.8M▼ 1.5% | 594.76M▼ 17.8% | 705.99M▲ 18.7% | 707.23M▲ 0.2% | 771.25M▲ 9.1% | 870.87M▲ 12.9% | 939.9M▲ 7.9% | 967.36M▲ 0% |
Gross Margin % | 64.37% | 66.35% | 66.76% | 63.66% | 68.19% | 69.21% | 66.86% | 69.48% | 67.71% | 67.48% |
Gross Profit Growth % | -7.5% | 12.72% | -1.46% | -17.83% | 18.7% | 0.17% | 9.05% | 12.92% | 7.93% | - |
Operating Expenses | 523.4M | 648.2M | 895.36M | 868.66M | 706.78M | 783.98M | 839.75M | 741.82M | 740.5M | 775.16M |
OpEx % of Revenue | 51.7% | 58.55% | 82.58% | 92.98% | 68.26% | 76.72% | 72.8% | 59.18% | 53.35% | - |
Selling, General & Admin | 380.6M | 465M | 0 | 0 | 471.9M | 469.24M | 518.13M | 526.26M | 548.8M | 563.25M |
SG&A % of Revenue | 37.6% | 42.01% | - | - | 45.58% | 45.92% | 44.92% | 41.99% | 39.54% | - |
Research & Development | 109.7M | 146M | 197.15M | 152.9M | 183.41M | 155.81M | 193.82M | 182.51M | 185.8M | 206.56M |
R&D % of Revenue | 10.84% | 13.19% | 18.18% | 16.37% | 17.71% | 15.25% | 16.8% | 14.56% | 13.39% | - |
Other Operating Expenses | 33.14M | 37.19M | 698.21M | 715.76M | 51.46M | 158.93M | 127.8M | 33.04M | 5.9M | 1.84M |
Operating Income | 95.7M▲ 0% | -248.1M▼ 359.2% | -171.55M▲ 30.9% | -273.9M▼ 59.7% | -784K▲ 99.7% | -76.75M▼ 9689.8% | -68.5M▲ 10.8% | 129.05M▲ 288.4% | 199.4M▲ 54.5% | 192.3M▲ 0% |
Operating Margin % | 9.45% | -22.41% | -15.82% | -29.32% | -0.08% | -7.51% | -5.94% | 10.3% | 14.37% | 13.41% |
Operating Income Growth % | 446.74% | -359.25% | 30.85% | -59.66% | 99.71% | -9689.8% | 10.75% | 288.4% | 54.51% | - |
EBITDA | 165.9M | -178.16M | -100.86M | -206.56M | 67.2M | -18.96M | -7.64M | 180.19M | 241.4M | 219.63M |
EBITDA Margin % | 16.39% | -16.09% | -9.3% | -22.11% | 6.49% | -1.86% | -0.66% | 14.38% | 17.39% | 15.32% |
EBITDA Growth % | 361.3% | -207.39% | 43.39% | -104.79% | 132.54% | -128.21% | 59.69% | 2457.96% | 33.97% | 2.58% |
D&A (Non-Cash Add-back) | 70.2M | 69.94M | 70.69M | 67.34M | 67.99M | 57.8M | 60.86M | 51.14M | 42M | 27.33M |
EBIT | 128.94M | -237.62M | 48.49M | -60.99M | -74.32M | -26.89M | -22.37M | 151.38M | -171.5M | 179.3M |
Net Interest Income | -6.48M | -8.98M | -14.29M | -40.71M | -49.72M | -43.55M | -36.84M | -32.99M | -49.3M | -20.1M |
Interest Income | 1.32M | 847K | 803K | 131K | 435K | 4.7M | 22.01M | 30.07M | 0 | 14.53M |
Interest Expense | 7.8M | 9.82M | 15.09M | 40.84M | 50.15M | 48.25M | 58.85M | 63.07M | 49.3M | 34.63M |
Other Income/Expense | 24.65M | 625K | 43.92M | -74.39M | -123.84M | 1.56M | -12.83M | -40.74M | -420.2M | -69.93M |
Pretax Income | 121.1M▲ 0% | -247.4M▼ 304.3% | -127.63M▲ 48.4% | -348.29M▼ 172.9% | -124.62M▲ 64.2% | -75.19M▲ 39.7% | -81.33M▼ 8.2% | 88.31M▲ 208.6% | -220.8M▼ 350.0% | 122.37M▲ 0% |
Pretax Margin % | 11.96% | -22.35% | -11.77% | -37.28% | -12.04% | -7.36% | -7.05% | 7.05% | -15.91% | 8.54% |
Income Tax | 49.95M | -69.63M | -30.37M | -960K | 11.2M | 11.05M | -98.88M | 25.06M | 21.6M | 14.4M |
Effective Tax Rate % | 41.25% | 28.14% | 23.8% | 0.28% | -8.99% | -14.7% | 121.57% | 28.38% | -9.78% | 11.77% |
Net Income | -25.1M▲ 0% | -189.4M▼ 654.6% | -157.64M▲ 16.8% | -348.82M▼ 121.3% | -135.82M▲ 61.1% | -86.25M▲ 36.5% | 17.55M▲ 120.3% | 63.23M▲ 260.4% | -242.5M▼ 483.5% | 107.14M▲ 0% |
Net Margin % | -2.48% | -17.11% | -14.54% | -37.34% | -13.12% | -8.44% | 1.52% | 5.04% | -17.47% | 7.47% |
Net Income Growth % | 60.03% | -654.58% | 16.77% | -121.28% | 61.06% | 36.5% | 120.34% | 260.39% | -483.5% | 148.23% |
Net Income (Continuing) | 71.18M | -177.82M | -158M | -347.33M | -135.82M | -86.25M | 17.55M | 63.25M | -242.5M | 107.12M |
Discontinued Operations | -79.55M | 0 | 365K | -1.49M | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.52▲ 0% | -3.91▼ 651.9% | -3.22▲ 17.6% | -7.06▼ 119.3% | -2.68▲ 62.0% | -1.61▲ 39.9% | 0.32▲ 119.9% | 1.16▲ 262.5% | -4.45▼ 483.6% | 1.92▲ 0% |
EPS Growth % | 59.38% | -651.92% | 17.65% | -119.25% | 62.04% | 39.93% | 119.88% | 262.5% | -483.62% | 147.92% |
EPS (Basic) | -0.52 | -3.91 | -3.22 | -7.06 | -2.68 | -1.61 | 0.33 | 1.17 | -4.45 | - |
Diluted Shares Outstanding | 48.5M | 48.5M | 48.35M | 48.59M | 50.63M | 53.5M | 54.21M | 54.57M | 54.5M | 55.9M |
Basic Shares Outstanding | 48.2M | 48.5M | 48.35M | 48.59M | 50.63M | 53.5M | 53.9M | 54.24M | 54.5M | 54.7M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
LIVN Balance Sheet
LivaNova PLC (LIVN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 869.9M | 533.3M | 549.44M | 708.04M | 679.18M | 886.14M | 988.16M | 1.13B | 1.1B | 1.01B |
Cash & Short-Term Investments | 93.6M | 47.2M | 61.14M | 252.83M | 207.99M | 214.17M | 266.5M | 428.86M | 635.6M | 539.7M |
Cash Only | 93.6M | 47.2M | 61.14M | 252.83M | 207.99M | 214.17M | 266.5M | 428.86M | 635.6M | 539.7M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 286.21M | 256.1M | 258.37M | 185.16M | 222.97M | 214.82M | 215.07M | 223.7M | 216M | 229.3M |
Days Sales Outstanding | 103.2 | 84.44 | 86.98 | 72.34 | 78.61 | 76.74 | 68.05 | 65.14 | 56.8 | 59.67 |
Inventory | 144.5M | 153.5M | 164.15M | 115.28M | 105.84M | 129.38M | 147.89M | 147.57M | 164.7M | 165.5M |
Days Inventory Outstanding | 146.22 | 150.41 | 166.27 | 123.95 | 117.29 | 150.12 | 141.2 | 140.79 | 134.13 | 129.81 |
Other Current Assets | 265.24M | 836K | 28M | 94.53M | 104.75M | 296.06M | 311.37M | 327.06M | 85.3M | 79.7M |
Total Non-Current Assets | 1.63B | 2.02B | 1.86B | 1.69B | 1.52B | 1.41B | 1.44B | 1.38B | 1.5B | 1.5B |
Property, Plant & Equipment | 192.4M | 191.4M | 235.73M | 214.33M | 190.67M | 183.02M | 205.03M | 217.1M | 298.1M | 310M |
Fixed Asset Turnover | 5.26x | 5.78x | 4.60x | 4.36x | 5.43x | 5.58x | 5.63x | 5.77x | 4.66x | 5.10x |
Goodwill | 784.2M | 956.8M | 915.79M | 922.32M | 899.52M | 768.79M | 782.94M | 750.01M | 792.8M | 785.6M |
Intangible Assets | 535.4M | 770.4M | 607.55M | 437.64M | 399.68M | 368.56M | 261.18M | 237.29M | 230M | 224.6M |
Long-Term Investments | 34.5M | 24.8M | 27.26M | 103.4M | 16.6M | 16.27M | 22.84M | 25.08M | 20.3M | 70.01M |
Other Non-Current Assets | 76M | 4.8M | 7.36M | 11.25M | 13.1M | 70.62M | 50.56M | 149.72M | 52.3M | 53.7M |
Total Assets | 2.5B▲ 0% | 2.55B▲ 1.8% | 2.41B▼ 5.4% | 2.4B▼ 0.5% | 2.2B▼ 8.3% | 2.29B▲ 4.3% | 2.43B▲ 5.9% | 2.51B▲ 3.2% | 2.61B▲ 4.0% | 2.52B▲ 0% |
Asset Turnover | 0.40x | 0.43x | 0.45x | 0.39x | 0.47x | 0.45x | 0.47x | 0.50x | 0.53x | 0.56x |
Asset Growth % | 6.89% | 1.83% | -5.41% | -0.49% | -8.29% | 4.26% | 5.87% | 3.16% | 3.98% | 5.92% |
Total Current Liabilities | 406M | 496.7M | 512.55M | 309.05M | 696.97M | 297.4M | 334.98M | 392.13M | 808.1M | 762.5M |
Accounts Payable | 85.92M | 76.73M | 85.89M | 73.67M | 68M | 74.31M | 80.84M | 69.73M | 97.2M | 99.1M |
Days Payables Outstanding | 86.94 | 75.19 | 87 | 79.21 | 75.36 | 86.22 | 77.19 | 66.52 | 79.16 | 72.71 |
Short-Term Debt | 84.03M | 28.79M | 88.51M | 24.62M | 229.67M | 23.43M | 18.11M | 78M | 31.5M | 2.6M |
Deferred Revenue (Current) | 2.9M | 391.3M | 0 | 6.93M | 8.42M | 10.23M | 10.72M | 10.85M | 0 | 22.26M |
Other Current Liabilities | 154.12M | 286.14M | 255.02M | 135.49M | 297.75M | 109.23M | 98.97M | 51.2M | 553.4M | 660.8M |
Current Ratio | 2.14x | 1.07x | 1.07x | 2.29x | 0.97x | 2.98x | 2.95x | 2.87x | 1.36x | 1.33x |
Quick Ratio | 1.79x | 0.76x | 0.75x | 1.92x | 0.82x | 2.54x | 2.51x | 2.50x | 1.16x | 1.11x |
Cash Conversion Cycle | 162.48 | 159.66 | 166.25 | 117.08 | 120.54 | 140.63 | 132.06 | 139.41 | 111.77 | 116.78 |
Total Non-Current Liabilities | 282.6M | 549.3M | 515.53M | 981.64M | 209.34M | 789.75M | 816.95M | 794.01M | 598M | 542.5M |
Long-Term Debt | 61.96M | 139.54M | 260.33M | 642.3M | 9.85M | 518.07M | 568.54M | 549.62M | 393.5M | 331.9M |
Capital Lease Obligations | 0 | 0 | 46.03M | 42.22M | 35.92M | 29.55M | 45.39M | 40.1M | 48.3M | 134.15M |
Deferred Tax Liabilities | 123.3M | 68.2M | 32.22M | 7.09M | 7.73M | 8.52M | 11.57M | 10.91M | 9.6M | 37.89M |
Other Non-Current Liabilities | 97.26M | 341.49M | 176.95M | 290.04M | 155.84M | 233.62M | 191.45M | 193.36M | 146.6M | 203.8M |
Total Liabilities | 688.6M | 1.05B | 1.03B | 1.29B | 906.31M | 1.09B | 1.15B | 1.19B | 1.41B | 1.3B |
Total Debt | 146M | 168.3M | 394.86M | 709.14M | 286.7M | 580.43M | 640.4M | 676.77M | 473.3M | 334.5M |
Net Debt | 52.4M | 121.1M | 333.73M | 456.31M | 78.71M | 366.26M | 373.9M | 247.91M | -162.3M | -205.2M |
Debt / Equity | 0.08x | 0.11x | 0.29x | 0.64x | 0.22x | 0.48x | 0.50x | 0.51x | 0.39x | 0.28x |
Debt / EBITDA | 0.88x | - | - | - | 4.27x | - | - | 3.76x | 1.96x | 1.52x |
Net Debt / EBITDA | 0.32x | - | - | - | 1.17x | - | - | 1.38x | -0.67x | -0.93x |
Interest Coverage | 16.54x | -24.19x | 3.21x | -1.49x | -1.48x | -0.56x | -0.38x | 2.40x | -3.48x | 5.18x |
Total Equity | 1.82B▲ 0% | 1.5B▼ 17.2% | 1.38B▼ 8.0% | 1.11B▼ 19.8% | 1.29B▲ 16.7% | 1.21B▼ 6.7% | 1.28B▲ 5.8% | 1.32B▲ 3.3% | 1.2B▼ 9.1% | 1.21B▲ 0% |
Equity Growth % | 6.35% | -17.17% | -7.98% | -19.83% | 16.71% | -6.72% | 5.8% | 3.34% | -9.11% | -13.29% |
Book Value per Share | 37.43 | 31.01 | 28.62 | 22.83 | 25.57 | 22.57 | 23.57 | 24.19 | 22.02 | 21.67 |
Total Shareholders' Equity | 1.82B | 1.5B | 1.38B | 1.11B | 1.29B | 1.21B | 1.28B | 1.32B | 1.2B | 1.21B |
Common Stock | 74.75M | 76.14M | 76.26M | 76.3M | 82.3M | 82.42M | 82.53M | 83.16M | 0 | 83.4M |
Retained Earnings | -39.66M | -251.58M | -406.75M | -761.97M | -897.78M | -984.03M | -966.48M | -903.25M | 0 | -1.12B |
Treasury Stock | -133K | -1.46M | -1.26M | -1.03M | -650K | -375K | -55K | -136K | 0 | 0 |
Accumulated OCI | 45.31M | -24.48M | -19.39M | 27.81M | -7.18M | -48.12M | -27.88M | -80.17M | 0 | -3.4M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LIVN Cash Flow Statement
LivaNova PLC (LIVN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 91.3M | 120.5M | -91.14M | -79.4M | 102.54M | 69.9M | 74.91M | 183.04M | 254.3M | 245.59M |
Operating CF Margin % | 9.02% | 10.89% | -8.41% | -8.5% | 9.9% | 6.84% | 6.49% | 14.6% | 18.32% | - |
Operating CF Growth % | 1.22% | 31.98% | -175.64% | 12.88% | 229.15% | -31.83% | 7.17% | 144.33% | 38.93% | 80.1% |
Net Income | -25.1M | -189.4M | -157.64M | -345M | -135.82M | -86.2M | 17.55M | 63.23M | -242.5M | 107.14M |
Depreciation & Amortization | 83M | 69.9M | 82.99M | 81.3M | 67.99M | 57.8M | 60.86M | 51.14M | 42M | 38.09M |
Stock-Based Compensation | 19.1M | 26.9M | 32.55M | 35.09M | 40.56M | 44.81M | 36.35M | 33.93M | 36.3M | 9.17M |
Deferred Taxes | -9.3M | -95.1M | -26.5M | 37.3M | 2.85M | 1.4M | -114.43M | 6.79M | 500K | 3.65M |
Other Non-Cash Items | 112.6M | 303.4M | 39.79M | 222.9M | 97.74M | 83.8M | 109.21M | 26.63M | 48.03M | 144.85M |
Working Capital Changes | -89M | 4.8M | -62.34M | -111M | 29.22M | -31.7M | -34.62M | 1.31M | 369.97M | -26.41M |
Change in Receivables | -48.9M | 21.2M | -5.32M | 58.8M | -15.74M | -4.8M | -28.86M | 11.1M | -10.7M | -21.48M |
Change in Inventory | 7.2M | -10.6M | -7.92M | 1.4M | 4.48M | -25.7M | -28.48M | -6.8M | -5.3M | -4.34M |
Change in Payables | -41.1M | 7.2M | -38.58M | -900K | 12.99M | -3.5M | 19.19M | -14.5M | -13.4M | -2.65M |
Cash from Investing | -52.9M | -120.6M | -41.29M | -41.8M | 36.9M | -38.4M | -40.33M | -48.16M | -72.9M | -76.86M |
Capital Expenditures | -34.1M | -38M | -24.69M | -35M | -25.48M | -26.5M | -34.98M | -47.11M | -81.1M | -84.52M |
CapEx % of Revenue | 3.37% | 3.43% | 2.28% | 3.75% | 2.46% | 2.59% | 3.03% | 3.76% | 5.84% | 5.9% |
Acquisitions | -14.2M | -93M | -10.75M | -1.7M | 41.25M | -8.9M | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -1.5M | 14.2M | -3.35M | -1.9M | 1.73M | -88K | 1.15M | 89K | 7.4M | 7.65M |
Cash from Financing | 11.3M | -42.3M | 146.58M | 310.8M | -181.48M | 280.1M | 21.48M | 18.55M | -285.7M | -375.48M |
Debt Issued (Net) | 11.69M | 29M | 172.95M | 407.05M | -487.85M | 284.01M | 26.4M | 87.97M | -280.93M | -372.49M |
Equity Issued (Net) | -4.08M | -61.61M | -7.06M | -5.6M | 322.56M | -8.67M | -7.5M | -8.44M | -4.39M | -4.39M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -4.08M | -61.61M | -7.06M | -5.6M | 0 | -8.7M | -7.5M | -8.44M | -4.43M | -4.43M |
Other Financing | 3.69M | -9.73M | -19.3M | -90.69M | -16.19M | 4.79M | 2.58M | -60.98M | -378K | 1.4M |
Net Change in Cash | 53.8M▲ 0% | -46.4M▼ 186.2% | 13.93M▲ 130.0% | 191.7M▲ 1275.9% | -44.84M▼ 123.4% | 307.6M▲ 786.0% | 62.25M▼ 79.8% | 145.68M▲ 134.0% | -88M▼ 160.4% | -198.73M▲ 0% |
Free Cash Flow | 57.2M▲ 0% | 82.5M▲ 44.2% | -115.83M▼ 240.4% | -114.4M▲ 1.2% | 77.07M▲ 167.4% | 43.4M▼ 43.7% | 39.93M▼ 8.0% | 135.93M▲ 240.4% | 173.2M▲ 27.4% | 161.08M▲ 0% |
FCF Margin % | 5.65% | 7.45% | -10.68% | -12.25% | 7.44% | 4.25% | 3.46% | 10.84% | 12.48% | 11.24% |
FCF Growth % | 7.92% | 44.23% | -240.4% | 1.24% | 167.37% | -43.68% | -7.99% | 240.4% | 27.42% | 10.69% |
FCF per Share | 1.18 | 1.70 | -2.40 | -2.35 | 1.52 | 0.81 | 0.74 | 2.49 | 3.18 | 2.88 |
FCF Conversion (FCF/Net Income) | -3.64x | -0.64x | 0.58x | 0.23x | -0.76x | -0.81x | 4.27x | 2.89x | -1.05x | 1.50x |
Interest Paid | 7.51M | 9.28M | 15.83M | 28.57M | 32.57M | 19.04M | 0 | 38.89M | 31.07M | 0 |
Taxes Paid | 38.97M | 26.39M | 2.01M | 7.49M | 0 | 1.22M | 0 | 15.91M | 29.37M | 0 |
LIVN Key Ratios
LivaNova PLC (LIVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -1.43% | -11.41% | -10.92% | -27.98% | -11.3% | -6.89% | 1.41% | 4.87% | -19.24% | 9.13% |
Return on Invested Capital (ROIC) | 3.92% | -10.66% | -7.7% | -12.51% | -0.04% | -3.91% | -3.19% | 6.01% | 11.48% | 14.23% |
Gross Margin | 64.37% | 66.35% | 66.76% | 63.66% | 68.19% | 69.21% | 66.86% | 69.48% | 67.71% | 67.48% |
Net Margin | -2.48% | -17.11% | -14.54% | -37.34% | -13.12% | -8.44% | 1.52% | 5.04% | -17.47% | 7.47% |
Debt / Equity | 0.08x | 0.11x | 0.29x | 0.64x | 0.22x | 0.48x | 0.50x | 0.51x | 0.39x | 0.28x |
Interest Coverage | 16.54x | -24.19x | 3.21x | -1.49x | -1.48x | -0.56x | -0.38x | 2.40x | -3.48x | 5.18x |
FCF Conversion | -3.64x | -0.64x | 0.58x | 0.23x | -0.76x | -0.81x | 4.27x | 2.89x | -1.05x | 1.50x |
Revenue Growth | -16.61% | 9.35% | -2.06% | -13.83% | 10.82% | -1.31% | 12.89% | 8.66% | 10.74% | 12.4% |
Related:LIVN Dividend History·LIVN Revenue History·LIVN Price History·LIVN P/E History·LIVN Financial Ratios·LIVN Institutional Holders
LIVN SEC Filings & Documents
LivaNova PLC (LIVN) SEC filings — annual & quarterly reports (10-K, 10-Q)
LIVN Frequently Asked Questions
LivaNova PLC (LIVN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LivaNova PLC (LIVN) reported $1.43B in revenue for fiscal year 2025. This represents a 143248% increase from $1.0M in 1995.
LivaNova PLC (LIVN) grew revenue by 10.7% over the past year. This is steady growth.
Yes, LivaNova PLC (LIVN) is profitable, generating $107.1M in net income for fiscal year 2025 (-17.5% net margin).
Dividend & Returns
LivaNova PLC (LIVN) has a return on equity (ROE) of -19.2%. Negative ROE indicates the company is unprofitable.
LivaNova PLC (LIVN) generated $161.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.